India Has Established a Storage Facility for Newborn Umbilical Cord Blood, Ensuring Future Treatment for Serious Diseases Using Stem Cells
 |
Containers for Storing Newborn Umbilical Cord Blood, a Source of Stem Cells |
Currently, over 4,000 Indian couples have stored their newborns’ umbilical cord blood with biotechnology companies, despite the storage cost being 60,000 Rupees.
They believe that with breakthroughs in stem cell research, their children’s health will be more secure in the future.
At present, two companies, Live Cell and Life Sciences Trust, have collectively stored 4,000 and 3,000 units, respectively.
Life Sciences Trust, founded just over a year ago, has partnered with Cryo-Cell International from the United States.
This company plans to open two more storage centers outside of India and hopes to achieve a revenue of 10 billion Rupees in the next five years, as 26 million children are born in India each year.
Stem cells are primitive cells capable of growing into any organ in the body. The blood drawn from the placenta and umbilical cord after birth contains a significant number of stem cells, which can assist in the treatment of over 75 severe diseases.
Diseases resulting from lifestyle choices, such as diabetes, liver imbalances, and heart disease, can also be treated with stem cells.
Snow Nhung
